The mitochondrion is an organelle that carries out a number of important metabolic processes such as fatty acid oxidation, the citric acid cycle, and oxidative phosphorylation. Mitochondrial oxidative phosphorylation supplies a large amount of energy that contributes to a range of cellular activities. However, this organelle is also the major source of cellular reactive oxygen species (ROS) that cause damage to mitochondrial lipid, DNA and proteins, and the accumulation of these types of damage are related to aging, cancer, and neurodegenerative diseases (
Wallace, 2005 
). Thus, intensive analyses of mitochondrial DNA repair and damaged protein degradation mechanisms have been carried out (
Larsson and Clayton, 1995 
;
Rep and Grivell, 1996 
;
Bogenhagen, 1999 
). In addition, it has long been assumed that autophagy is the pathway for mitochondrial recycling, and various theories suggest that a specific targeting of damaged mitochondria to vacuoles or lysosomes occurs by autophagy (
Abeliovich and Klionsky, 2001 
). Very recently, several studies suggest that selective mitochondrial degradation via autophagy (mitophagy) might play an important role for mitochondrial quality control (
Priault et al., 2005 
;
Mijaljica et al., 2007 
;
Nowikovsky et al., 2007 
;
Zhang et al., 2007 
;
Twig et al., 2008 
). However, the molecular mechanism of mitophagy is poorly understood.
Macroautophagy is the bulk (i.e., nonspecific) degradation of cytoplasmic components that allows cells to respond to various types of stress and to adapt to changing nutrient conditions (
Klionsky, 2005 
;
Yorimitsu and Klionsky, 2007 
). In contrast to macroautophagy, the cytoplasm-to-vacuole targeting (Cvt) pathway, pexophagy (specific autophagy of peroxisomes), and mitophagy are categorized as selective types of autophagy. These processes have specific cargos comprised of the Cvt complex (precursor aminopeptidase I (prApe1) and α-mannosidase (Ams1), along with receptor and adaptor proteins), peroxisomes and mitochondria, respectively (
Shintani et al., 2002 
;
Dunn et al., 2005 
;
Farre et al., 2008 
;
Kanki and Klionsky, 2008 
). Studies in the yeast
Saccharomyces cerevisiae and other fungi have enabled the identification of several molecular factors essential for autophagy (
Yorimitsu and Klionsky, 2005 
). At present, there are 32 genes that are primarily involved in autophagy-related (Atg) pathways. Most of the
ATG genes are required for both macroautophagy and selective autophagy, but some are required only for specific types of autophagy (
Kanki and Klionsky, 2008 
). For example, Atg19, a receptor protein for the Cvt pathway, binds the Cvt complex, and then interacts with Atg11, an adaptor protein for selective autophagy, and recruits them to the phagophore assembly site (PAS), where the sequestering cytosolic vesicles are generated (
Shintani et al., 2002 
). Similarly, during pexophagy in
Pichia pastoris, Atg30 localizes to peroxisomes, where it is bound by Atg11, allowing recruitment of the peroxisomes to the PAS (
Farre et al., 2008 
). Atg11 is also required for mitochondrial degradation during starvation or in post-log phase, suggesting that mitochondria are selected by Atg11 for autophagic degradation (
Kanki and Klionsky, 2008 
). Recently, we identified Atg32 as a mitochondrial protein that interacts with Atg11 and is required specifically for mitophagy (
Kanki et al., 2009 
;
Okamoto et al., 2009 
); however, the detailed mechanism of mitophagy has not been determined.
To figure out the molecular mechanism of selective mitochondria autophagy, we recently established a method to monitor this process (
Kanki and Klionsky, 2008 
). Using this method, we screened a yeast knockout library for strains that are deficient in mitophagy. Among 4667 strains, we found 32 strains that showed a complete or partial block of mitophagy, in addition to the
ATG gene knockout strains. We also screened these mutants to ascertain the functionality of macroautophagy and the Cvt pathway. Nine of the strains showed defects in all autophagic pathways, whereas the other 23 strains were normal for the Cvt pathway, but defective to varying extents for macroautophagy and mitophagy. We further characterized the product of one of the genes,
YLR356W, whose function has not been previously identified. The Ylr356w protein localized to mitochondria, and the deletion of
YLR356W resulted in an almost complete inhibition of mitophagy at post-log phase.